Maalox plus - adjuvant hyperacidity 50 tablets chewable

Product Description

Adjuvant in gastric hyperacidity and dyspepsia caused by hyperacidity, even in the presence of meteorism.

Indications

Maalox Plus chewable tablets is a symptomatic treatment for heartburn and gastric pain and esophagitis.
Adjuvant in the treatment of gastroduodenal ulcers.

Composition

Active ingredients

Magnesium hydroxide 200 mg, aluminum oxide, hydrate 200 mg, dimethicone 25 mg.

Excipients

Magnesium hydroxide 200 mg, aluminum oxide, hydrate 200 mg, dimethicone 25 mg.

Directions for use and Dosage

The tablets should be chewed or sucked well. They can be taken with water or milk.
Administration of the medicine in children is not recommended.

Warnings

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. This medicine contains 0.5 g of glucose per dose. To be taken into consideration in patients with diabetes mellitus.

Interactions

Since Al and Mg salts reduce the gastrointestinal absorption of tetracyclines, it is recommended to avoid taking Maalox Plus during oral tetracycline therapy. The use of antacids containing aluminum may increase the risk of tetracycline overdose. Reduce the absorption of drugs such as H2 antagonists, atenolol, cefdinir, cefpodoxime, chloroquine, tetracyclines, diflunisal, digoxin, bisphosphonates, ethambutol, fluoroquinolones, sodium fluoride, glucocorticoids, indomethacin, isoniazid, ketoconazole, levothyroxine, lincosamides, metoprolol, phenothiazine neuroleptics, penicillamine, propranolol, rosuvastatin, iron salts. Polystyrene sulfonate (Kayexalate) Caution is advised when taking this medicine with polystyrene sulfonate (Kayexalate) due to the potential risk of reduced potassium-binding efficacy of the resin, metabolic alkalosis in patients with renal impairment (reported with aluminum hydroxide and magnesium hydroxide), and intestinal obstruction (reported with aluminum hydroxide). Aluminum hydroxide and citrates may cause hyperaluminemia, especially in patients with renal impairment. Allow at least two hours (4 for fluoroquinolones) to elapse before taking Maalox to avoid interactions with other drugs. Concomitant use of quinidine may cause increased serum quinidine levels and lead to quinidine overdose. Concomitant use of aluminum hydroxide and citrates may lead to increased aluminum levels, particularly in patients with renal impairment.

Pregnancy and breastfeeding

Pregnancy The medicine should be used only when necessary, under the direct supervision of a doctor, after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant. Breastfeeding Due to limited maternal absorption when taken according to the indicated dosage regimen, aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding.

Storage

Store below 25°C.

Format

50 chewable tablets.